Furthermore, a multiple linear regression analysis suggests that the reduction in GDF-15 at 1 year from baseline was associated with a greater PWL after anti-obesity treatments. The gene discussed is GDF15; the disease is obesity due to melanocortin 4 receptor deficiency.